Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol in Trichotillomania and Skin-Picking Disorder
NCT03530800Phase 3Completed
- Sponsor
- University of Chicago
- Start
- Oct 2018
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dronabinol in trichotillomania (TTM), Excoriation disorder (SPD), sponsored by University of Chicago. Started Oct 2018; status: completed.
02
Drugs
dronabinol
03
Conditions
trichotillomania (TTM)Excoriation disorder (SPD)
Beyond the preview
Go deeper on NCT03530800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03530800.